Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Knowing when to start planning for retirement is crucial. Explore the best age to begin your retirement journey for financial security.
25,576 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A baby boomer dad who spent years cleaning overnight helped his five children attend a private college tuition-free, ...
Oracle’s shares have fallen sharply this year, leaving investors wondering if the decline creates a buying opportunit...
When a company executive moves tens of thousands of shares, it sparks questions. This guide explains what insider sel...
When a global star resurfaces at a major awards show, money, trust, and hype collide. This piece breaks down the cont...
Metallus faces a dynamic metals market in 2025. This guide breaks down expected MTUS 2025 earnings, the drivers behin...
Midweek market news can move fast. This Wednesday reads guide curates clear, actionable investing ideas—from AI hype ...
Investors weighing a gold-only ETF versus a silver-backed ETF face a tradeoff: gold offers lower volatility and costs...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
Oklo is building small modular reactors with a bold future. But should oklo stock while it trades under $55 be part o...
A coalition of rap legends led by Travis Scott takes a bold legal stand at the Supreme Court. This isn’t just a court...
SpaceX is redefining its business beyond rocket launches. This article explains the spacex made huge pivot, what it c...